Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,536 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,903 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04207255 | Addition of Opaganib to Androgen Antagonists in Patients With mCRPC | completed | Phase 2 | 69 | Medical University of South CarolinaOTHER | 1 | Sep 25, 2024 | clinicaltrials |
| NCT04672460 | A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors | completed | Phase 1 | 73 | PfizerINDUSTRY | 2 | Sep 25, 2024 |
| NCT00365105 | Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer | completed | Phase 3 | 261 | Radiation Therapy Oncology GroupNETWORK | 1 | Sep 20, 2024 | clinicaltrials |
| NCT00580476 | Assessing Depression in a Geriatric Cancer Population | completed | — | 201 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT02099864 | Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy | completed | Phase 2 | 36 | OHSU Knight Cancer InstituteOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT03558711 | PSMA-PET/CT for Prostate Cancer(NGP1) | completed | Phase 1 | 6 | University Hospital, GhentOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT03585660 | Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer Biopsy | completed | N/A | 106 | University of ChicagoOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT04733768 | 18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate Cancer | completed | Phase 2 | 100 | University of AlbertaOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT04852224 | Strength, Aging, and Memory in Prostate Cancer(STAMP) | completed | — | 20 | University of NebraskaOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05318131 | Sleep, Exercise, Nutrition and Survivorship in Prostate Cancer | completed | N/A | 50 | NYU Langone HealthOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05700669 | Study to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid Tumors | completed | Phase 1 / Phase 2 | 3 | Valerio TherapeuticsINDUSTRY | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06601205 | Finasteride and Flutamide in Pre-surgical Trial in Prostate Cancer.(2F) | completed | Phase 2 / Phase 3 | 125 | Ente Ospedaliero Ospedali GallieraOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06604247 | The Association Between CBT-I Dose and Innate Immunity in Insomnia and Fatigue in Prostate Cancer Patients | completed | N/A | 18 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06604377 | Model of Predicting Biochemical Recurrence After Radical Prostate Cancer Based on Pre-treatment PSMA PET / MR Image Features | completed | — | 203 | Ruijin HospitalOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT03579680 | De-implementation of Low Value Castration for Men With Prostate Cancer(DeADT) | completed | N/A | 60 | University of MichiganOTHER | 1 | Sep 5, 2024 | clinicaltrials |
| NCT03867357 | Intramuscular Mechanisms of Androgen Deprivation-related Sarcopenia | completed | — | 60 | Seattle Institute for Biomedical and Clinical ResearchOTHER | 1 | Sep 4, 2024 | clinicaltrials |
| NCT02566772 | Study of TAS3681 in Metastatic Castration Resistant Prostate Cancer | completed | Phase 1 | 130 | Taiho Oncology, Inc.INDUSTRY | 4 | Sep 3, 2024 | clinicaltrials |
| NCT02952469 | Biodistribution/Reproducibility Ga-68 PSMA-HBED-CC | completed | Early Phase 1 | 22 | University of IowaOTHER | 1 | Sep 3, 2024 | clinicaltrials |
| NCT01272050 | Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After Surgery | completed | Phase 3 | 350 | Swiss Cancer InstituteOTHER | 3 | Aug 28, 2024 | clinicaltrials |
| NCT02431676 | Survivorship Promotion In Reducing IGF-1 Trial(SPIRIT) | completed | Phase 2 | 121 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT03473925 | Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034) | completed | Phase 2 | 107 | Merck Sharp & Dohme LLCINDUSTRY | 5 | Aug 28, 2024 | clinicaltrials |
| NCT03870269 | Using Virtual Reality (VR) Models for Robotic Prostatectomy - UNC | completed | N/A | 28 | Ceevra, Inc.INDUSTRY | 1 | Aug 28, 2024 | clinicaltrials |
| NCT00936936 | High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors | completed | Phase 2 | 64 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 26, 2024 | clinicaltrials |
| NCT01716702 | A Feasibility Study of an Online Intervention for Sexual Rehabilitation in Prostate Cancer | completed | N/A | 18 | Nova Scotia Health AuthorityOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT04485767 | RESIST-ADT (Androgen Deprivation Therapy) | completed | N/A | 21 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 20, 2024 | clinicaltrials |
| NCT05615909 | PRO-MR-RT Systematic Patient-reported Outcomes to Pelvic Online MRgRT | completed | — | 156 | Odense University HospitalOTHER | 1 | Aug 19, 2024 | clinicaltrials |
| NCT04067960 | Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer | completed | Early Phase 1 | 197 | Mayo ClinicOTHER | 1 | Aug 14, 2024 | clinicaltrials |
| NCT00953277 | Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer | completed | Phase 4 | 12 | Axogen CorporationINDUSTRY | 1 | Aug 12, 2024 | clinicaltrials |
| NCT05132868 | Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counseling | completed | N/A | 78 | Stanford UniversityOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT03133286 | Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)(RADIANT) | completed | — | 16 | DxTerity DiagnosticsINDUSTRY | 1 | Aug 7, 2024 | clinicaltrials |
| NCT01685268 | A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate | completed | Phase 1 / Phase 2 | 49 | Astex Pharmaceuticals, Inc.INDUSTRY | 4 | Aug 2, 2024 | clinicaltrials |
| NCT03336983 | Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients(BonEnza) | completed | Phase 2 | 126 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaOTHER | 1 | Aug 1, 2024 | clinicaltrials |
| NCT03339635 | Short-term Testosterone Replacement in Testicular Cancer Survivors | completed | Phase 2 | 32 | University Medical Center GroningenOTHER | 1 | Jul 30, 2024 | clinicaltrials |
| NCT04488068 | Transpelvic Magnetic Stimulation to Improve Urogenital Function | completed | N/A | 12 | VA Office of Research and DevelopmentFED | 1 | Jul 29, 2024 | clinicaltrials |
| NCT05120973 | Multispectral Fluorescence as a Tool to Separate Healthy and Disease Related Lymphatic Anatomies in Prostate Cancer.(SPLIT) | completed | — | 26 | The Netherlands Cancer InstituteOTHER | 1 | Jul 29, 2024 | clinicaltrials |
| NCT04693507 | Teverelix Evaluated in Advanced Prostate Cancer(TEACh) | completed | Phase 2 | 50 | Antev Ltd.INDUSTRY | 1 | Jul 23, 2024 | clinicaltrials |
| NCT06145243 | Comparison of the Effectiveness of Supervised, Video-based and Home-based Resistance Exercise Program in Patients With Prostate Cancer | completed | N/A | 60 | Acibadem UniversityOTHER | 1 | Jul 19, 2024 | clinicaltrials |
| NCT03017417 | A COMbined progRamme of Exercise and Dietary ADvice in mEn With Castrate Resistant Prostate Cancer(COMRADE) | completed | N/A | 31 | Sheffield Teaching Hospitals NHS Foundation TrustOTHER | 1 | Jul 18, 2024 | clinicaltrials |
| NCT05958004 | The Application Value of Prostate Specific Membrane Antigen PET/CT in Biopsy Free of PSA Grey Area Prostate Cancer | completed | — | 92 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Jul 17, 2024 | clinicaltrials |
| NCT03389451 | 68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer | completed | Phase 2 / Phase 3 | 30 | Michael Graham PhD, MDOTHER | 1 | Jul 12, 2024 | clinicaltrials |
| NCT04701021 | TENDU Vaccine in Patients With Relapse After Primary Radical Prostatectomy | completed | Phase 1 | 12 | Ultimovacs ASAINDUSTRY | 1 | Jul 8, 2024 | clinicaltrials |
| NCT01446731 | Dendritic Cell Vaccination and Docetaxel for Patients With Prostate Cancer | completed | Phase 2 | 43 | Inge Marie SvaneOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT03030625 | VMAT for Dominant Intraprostatic Lesion(CaP-VMAT-DIL) | completed | N/A | 30 | Fundación de Investigación Biomédica - Hospital Universitario de La PrincesaOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06484127 | Heterogeneity of Tertiary Lymphoid Structures Predicts Distinct Malignancy and Immune Microenvironment in Prostate Cancer: a Retrospective Cohort Study | completed | — | 200 | Fudan UniversityOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT05578820 | Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid | completed | Phase 1 | 21 | Gene Surgery LLCINDUSTRY | 1 | Jul 1, 2024 | clinicaltrials |
| NCT03220945 | Comprehensive Yoga Program (SKY) as Adjunct Therapy for Prostate Cancer | completed | N/A | 45 | Emory UniversityOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT04408924 | Abemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resistant Prostate Cancer(CYCLONE 1) | completed | Phase 2 | 44 | Eli Lilly and CompanyINDUSTRY | 3 | Jun 25, 2024 | clinicaltrials |
Data updated 24 days agoSource updated Sep 25, 2024source: clinicaltrials